1. Home
  2. HP vs LGND Comparison

HP vs LGND Comparison

Compare HP & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helmerich & Payne Inc.

HP

Helmerich & Payne Inc.

HOLD

Current Price

$35.22

Market Cap

3.7B

Sector

Energy

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$204.85

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HP
LGND
Founded
1920
1987
Country
United States
United States
Employees
N/A
68
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
HP
LGND
Price
$35.22
$204.85
Analyst Decision
Hold
Strong Buy
Analyst Count
12
7
Target Price
$33.08
$245.86
AVG Volume (30 Days)
1.3M
193.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,746,013,000.00
N/A
Revenue This Year
$9.48
$1.61
Revenue Next Year
$3.00
$18.93
P/E Ratio
N/A
$76.27
Revenue Growth
35.89
N/A
52 Week Low
$14.65
$98.90
52 Week High
$37.87
$227.92

Technical Indicators

Market Signals
Indicator
HP
LGND
Relative Strength Index (RSI) 49.65 53.41
Support Level $32.53 $197.34
Resistance Level $36.39 $207.72
Average True Range (ATR) 1.27 8.03
MACD -0.17 0.11
Stochastic Oscillator 37.58 65.12

Price Performance

Historical Comparison
HP
LGND

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: